Scarica l'app Stockscreener
41.08
0.70%
-0.29
Pre-mercato:
41.08
Qiagen Nv Borsa (QGEN) Ultime notizie
Qiagen Sees Unusually High Options Volume (NYSE:QGEN) - MarketBeat
Qiagen stock holds firm as diagnostics demand supports growth outlook - Ad-hoc-news.de
Qiagen NV (QGEN) Cash Flow - TradingKey
Qiagen NV (QGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Troluce Capital Advisors LLC Purchases Shares of 362,500 Qiagen N.V. $QGEN - MarketBeat
Sona Asset Management US LLC Invests $8.89 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. $QGEN Holdings Cut by Bank of New York Mellon Corp - MarketBeat
Qiagen stock trades steady as latest results highlight consumables growth and margin resilience - Ad-hoc-news.de
QGEN|Qiagen NV|Price:41.370|Chg%:-0.050 - TradingKey
Qiagen NV (QGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Qiagen NV (QGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Qiagen NV (QGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Qiagen NV (QGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Qiagen stock trades steady as diagnostics demand supports revenue growth - Ad-hoc-news.de
Bessemer Group Inc. Sells 43,977 Shares of Qiagen N.V. $QGEN - MarketBeat
Qiagen stock trades steadily as investors weigh Q2 2026 earnings and molecular diagnostics growth - Ad-hoc-news.de
BlackRock builds 11.6% stake in Qiagen, lifting voting power to 13% - The Globe and Mail
Qiagen stock trades steady as investors weigh Q2 2026 revenue momentum and margin trends - Ad-hoc-news.de
Sei Investments Co. Decreases Stock Holdings in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock trades steady as investors weigh recent earnings and diagnostics demand - Ad-hoc-news.de
Qiagen stock stays supported as molecular testing demand underpins growth - Ad-hoc-news.de
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen stock steadies as investors await fresh numbers - AD HOC NEWS
Does Qiagen's Expanded QIAstat-Dx Infection and AMR Menu Reframe the Bull Case for QGEN? - simplywall.st
Qiagen stock trades steadily as molecular diagnostics growth supports margins - Ad-hoc-news.de
Qiagen N.V. $QGEN Shares Acquired by Swiss National Bank - MarketBeat
Capula Management Ltd Purchases New Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen NV (QGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Qiagen stock steadies as latest results highlight margin resilience and cash flow strength - AD HOC NEWS
AFM Filing Reveals BlackRock Builds Significant Stake in Qiagen - The Globe and Mail
Qiagen stock trades steadily as investors weigh recent earnings and molecular diagnostics growth - Ad-hoc-news.de
Qiagen stock holds steady as 2025 revenue and profit metrics frame the setup - Ad-hoc-news.de
Hsbc Holdings PLC Invests $12.92 Million in Qiagen N.V. $QGEN - MarketBeat
KKR (KKR) After Qiagen Interest And Allyntra Launch Has Valuation Back In Focus - Yahoo Finance
Qiagen stock steadies as investors weigh recent earnings and molecular diagnostics growth - Ad-hoc-news.de
KKR (KKR) Launches Allyntra While Chasing DStelecom And Qiagen - Yahoo Finance
Qiagen stock trades steady as diagnostics revenue grows and margin focus intensifies - Ad-hoc-news.de
Qiagen stock trades steady as diagnostics demand supports earnings momentum - AD HOC NEWS
Barclays lifts QIAGEN voting rights stake to 3.19% - Bitget
Qiagen stock trades steady as diagnostics demand supports recent earnings - AD HOC NEWS
Qiagen stock holds firm as diagnostics demand supports revenue growth - Ad-hoc-news.de
Qiagen stock trades steady as recent results highlight margin resilience - Ad-hoc-news.de
Qiagen stock rises on recent results and market data - Ad-hoc-news.de
Baader Bank Aktiengesellschaft Buys New Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock trades steadily as diagnostics demand supports earnings and cash flow - Ad-hoc-news.de
Qiagen stock trades steadily as recent earnings and margin trends shape investor focus - Ad-hoc-news.de
Qiagen N.V. (QGEN) Stock Analysis: Evaluating The 7.09% Upside Potential For Investors - DirectorsTalk Interviews
DekaBank Deutsche Girozentrale Takes $10.81 Million Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock holds as investors await fresh numbers - Ad-hoc-news.de
Qiagen stock trades steady as latest quarterly numbers highlight margin resilience - Ad-hoc-news.de
William Blair Initiates Qiagen NV(QGEN.US) With Hold Rating - Moomoo
Qiagen stock trades steadily as recent earnings and guidance frame valuation - ad-hoc-news.de
Qiagen stock steadies as investors weigh Q2 2025 earnings and diagnostics demand - ad-hoc-news.de
Qiagen stock rises on 2025 results and 2026 guidance - ad-hoc-news.de
Qiagen stock trades steady as diagnostics demand supports earnings and cash flow - Ad-hoc-news.de
BlackRock Builds Significant Stake in Qiagen, Boosting Institutional Presence - The Globe and Mail
Citigroup Discloses 2.85% Stake in QIAGEN via AFM Filing - The Globe and Mail
Citigroup Reports 3.09% Indirect Stake in Qiagen via AFM Filing - The Globe and Mail
Goldman Sachs discloses 3.5% voting interest in Qiagen - The Globe and Mail
Qiagen stock holds ground as investors look to next earnings after steady 2024 revenue - ad-hoc-news.de
Allspring Global Investments Holdings LLC Has $100.21 Million Position in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock holds near recent levels as earnings metrics guide the story - ad-hoc-news.de
Qiagen stock holds steady as 2026 guidance and margins stay central - ad-hoc-news.de
Qiagen (QGEN) Investor presentation Summary - Quartr
Qiagen stock trades steady as Q1 2026 growth and margin resilience underpin outlook - ad-hoc-news.de
Qiagen stock trades steady as investors weigh Q1 2024 growth and margin trends - ad-hoc-news.de
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate - GlobeNewswire Inc.
Barings LLC Sells 77,747 Shares of Qiagen N.V. $QGEN - MarketBeat
1.75%
2.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):